Tag Archives: NASDAQ:AMGN

Amgen (AMGN) Receives a Buy from Credit Suisse

Credit Suisse analyst Evan Seigerman maintained a Buy rating on Amgen (AMGN – Research Report) on January 30 and set a price target of $252.00. The company’s shares closed last Monday at $216.05. According to TipRanks.com, Seigerman is a 4-star

Analysts Are Neutral on These Healthcare Stocks: Amgen (AMGN), Edwards Lifesciences (EW)

Analysts fell to the sidelines weighing in on Amgen (AMGN – Research Report) and Edwards Lifesciences (EW – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Amgen (AMGN) J.P. Morgan analyst

Amgen (AMGN) Gets a Buy Rating from Oppenheimer

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $256.00. The company’s shares closed last Monday at $212.80. According to TipRanks.com, Olson ‘s ranking currently consits of no

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Miragen Therapeutics (NASDAQ: MGEN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN – Research Report) and Miragen Therapeutics (MGEN – Research Report) with bullish sentiments. Amgen (AMGN) In a report released today,

Amgen (AMGN) Gets a Hold Rating from Mizuho Securities

Mizuho Securities analyst Salim Syed maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $215.00. The company’s shares closed last Monday at $226.15. According to TipRanks.com, Syed ‘s ranking currently consits of

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and IMV (NASDAQ: IMV)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN – Research Report) and IMV (IMV – Research Report). Amgen (AMGN) In a report issued on January 14, Cory Kasimov from